Patients with impaired glucose tolerance who underwent metformin therapy or intense lifestyle intervention attained significant reductions in bad-cholesterol particles and increased levels of good cholesterol, a study in the Journal of Clinical Endocrinology & Metabolism showed. "Our findings demonstrate that the same therapies used to slow the onset of diabetes also may help allay the risk of heart disease," researcher Dr. Ronald Goldberg said in a statement.

Related Summaries